Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel

MarketBeat Instant News Alerts

Acumen Pharmaceuticals logo with Medical background

ADAR1 Capital Management LLC Acquires 1,265,151 Shares of Acumen Pharmaceuticals, Inc. $ABOS

MarketBeat

ADAR1 Capital Management LLC lifted its holdings in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Free Report) by 142.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,156,334 shares of the company's stock after bu

NASDAQ:ABOS
Read ADAR1 Capital Management LLC Acquires 1,265,151 Shares of Acumen Pharmaceuticals, Inc. $ABOS
Sarepta Therapeutics logo with Medical background

ADAR1 Capital Management LLC Has $5.70 Million Holdings in Sarepta Therapeutics, Inc. $SRPT

MarketBeat

ADAR1 Capital Management LLC grew its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 807.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 262,058 shares of the biotechnology company's

NASDAQ:SRPT
Read ADAR1 Capital Management LLC Has $5.70 Million Holdings in Sarepta Therapeutics, Inc. $SRPT
Insmed logo with Medical background

ADAR1 Capital Management LLC Invests $5.79 Million in Insmed, Inc. $INSM

MarketBeat

ADAR1 Capital Management LLC bought a new position in Insmed, Inc. (NASDAQ:INSM - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 35,392 shares of the biopharmaceutical company's stock, valued at approxi

NASDAQ:INSM
Read ADAR1 Capital Management LLC Invests $5.79 Million in Insmed, Inc. $INSM
Danaher logo with Medical background

Danaher Corporation $DHR Stock Holdings Increased by ADAR1 Capital Management LLC

MarketBeat

ADAR1 Capital Management LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 20.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 30,932 shares of the conglomerate's stock after acquiring an additional 5,332 shares during the qu

NYSE:DHR
Read Danaher Corporation $DHR Stock Holdings Increased by ADAR1 Capital Management LLC
Viridian Therapeutics logo with Medical background

ADAR1 Capital Management LLC Raises Stock Position in Viridian Therapeutics, Inc. $VRDN

MarketBeat

ADAR1 Capital Management LLC lifted its position in Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 294.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 304,422 shares of the company's

NASDAQ:VRDN
Read ADAR1 Capital Management LLC Raises Stock Position in Viridian Therapeutics, Inc. $VRDN
Korro Bio logo with Medical background

ADAR1 Capital Management LLC Takes Position in Korro Bio, Inc. $KRRO

MarketBeat

ADAR1 Capital Management LLC acquired a new stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 540,054 shares of the company's stock, valued at approximately $6,113,000. ADAR1 Capital Management LLC owned 3.75

NASDAQ:KRRO
Read ADAR1 Capital Management LLC Takes Position in Korro Bio, Inc. $KRRO

Trending News

1Southpoint Capital Advisors LP Buys 300,000 Shares of Advanced Micro Devices, Inc. $AMD
2Nebius Group (NASDAQ:NBIS) Shares Down 15% - What's Next?
3Brokers Offer Predictions for Nokia's Q3 Earnings (NYSE:NOK)
4Renaissance Technologies LLC Purchases 5,962,731 Shares of NIO Inc. $NIO
5Apple (NASDAQ:AAPL) Stock Price Expected to Rise, Robert W. Baird Analyst Says
6Nintendo (OTCMKTS:NTDOY) Shares Gap Up - Here's Why
7Healthcare of Ontario Pension Plan Trust Fund Buys Shares of 3,750,000 The Wendy's Company $WEN
8Wedbush Issues Positive Forecast for Advanced Micro Devices (NASDAQ:AMD) Stock Price

All MarketBeat Instant News Alerts

Urogen Pharma logo with Medical background

ADAR1 Capital Management LLC Boosts Stock Position in Urogen Pharma $URGN

MarketBeat
NASDAQ:URGN
Read ADAR1 Capital Management LLC Boosts Stock Position in Urogen Pharma $URGN
Maplight Therapeutics logo with Manufacturing background

ADAR1 Capital Management LLC Purchases New Position in Maplight Therapeutics, Inc. $MPLT

MarketBeat
NASDAQ:MPLT
Read ADAR1 Capital Management LLC Purchases New Position in Maplight Therapeutics, Inc. $MPLT
Teva Pharmaceutical Industries logo with Medical background

Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by ADAR1 Capital Management LLC

MarketBeat
NYSE:TEVA
Read Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by ADAR1 Capital Management LLC
OnKure Therapeutics logo with Medical background

ADAR1 Capital Management LLC Acquires 1,420,783 Shares of OnKure Therapeutics, Inc. $OKUR

MarketBeat
NASDAQ:OKUR
Read ADAR1 Capital Management LLC Acquires 1,420,783 Shares of OnKure Therapeutics, Inc. $OKUR
ARS Pharmaceuticals logo with Medical background

ARS Pharmaceuticals, Inc. $SPRY Shares Purchased by ADAR1 Capital Management LLC

MarketBeat
NASDAQ:SPRY
Read ARS Pharmaceuticals, Inc. $SPRY Shares Purchased by ADAR1 Capital Management LLC
Inhibikase Therapeutics logo with Manufacturing background

ADAR1 Capital Management LLC Reduces Stock Position in Inhibikase Therapeutics, Inc. $IKT

MarketBeat
NASDAQ:IKT
Read ADAR1 Capital Management LLC Reduces Stock Position in Inhibikase Therapeutics, Inc. $IKT
Establishment Labs logo with Medical background

Establishment Labs Holdings Inc. $ESTA Shares Acquired by ADAR1 Capital Management LLC

MarketBeat
NASDAQ:ESTA
Read Establishment Labs Holdings Inc. $ESTA Shares Acquired by ADAR1 Capital Management LLC
CG Oncology logo with Medical background

ADAR1 Capital Management LLC Sells 72,440 Shares of CG Oncology, Inc. $CGON

MarketBeat
NASDAQ:CGON
Read ADAR1 Capital Management LLC Sells 72,440 Shares of CG Oncology, Inc. $CGON
Enliven Therapeutics logo with Medical background

ADAR1 Capital Management LLC Has $12.92 Million Holdings in Enliven Therapeutics, Inc. $ELVN

MarketBeat
NASDAQ:ELVN
Read ADAR1 Capital Management LLC Has $12.92 Million Holdings in Enliven Therapeutics, Inc. $ELVN
Revolution Medicines logo with Medical background

ADAR1 Capital Management LLC Lowers Stock Position in Revolution Medicines, Inc. $RVMD

MarketBeat
NASDAQ:RVMD
Read ADAR1 Capital Management LLC Lowers Stock Position in Revolution Medicines, Inc. $RVMD
Taysha Gene Therapies logo with Medical background

ADAR1 Capital Management LLC Has $13.32 Million Stock Position in Taysha Gene Therapies, Inc. $TSHA

MarketBeat
NASDAQ:TSHA
Read ADAR1 Capital Management LLC Has $13.32 Million Stock Position in Taysha Gene Therapies, Inc. $TSHA
Celldex Therapeutics logo with Medical background

ADAR1 Capital Management LLC Lowers Holdings in Celldex Therapeutics, Inc. $CLDX

MarketBeat
NASDAQ:CLDX
Read ADAR1 Capital Management LLC Lowers Holdings in Celldex Therapeutics, Inc. $CLDX
Amylyx Pharmaceuticals logo with Medical background

ADAR1 Capital Management LLC Buys 110,248 Shares of Amylyx Pharmaceuticals, Inc. $AMLX

MarketBeat
NASDAQ:AMLX
Read ADAR1 Capital Management LLC Buys 110,248 Shares of Amylyx Pharmaceuticals, Inc. $AMLX
Monopar Therapeutics logo with Medical background

Monopar Therapeutics Inc. $MNPR Position Increased by ADAR1 Capital Management LLC

MarketBeat
NASDAQ:MNPR
Read Monopar Therapeutics Inc. $MNPR Position Increased by ADAR1 Capital Management LLC
Vaxcyte logo with Medical background

ADAR1 Capital Management LLC Trims Holdings in Vaxcyte, Inc. $PCVX

MarketBeat
NASDAQ:PCVX
Read ADAR1 Capital Management LLC Trims Holdings in Vaxcyte, Inc. $PCVX
Prothena logo with Medical background

Prothena Corporation plc $PRTA Shares Purchased by ADAR1 Capital Management LLC

MarketBeat
NASDAQ:PRTA
Read Prothena Corporation plc $PRTA Shares Purchased by ADAR1 Capital Management LLC
Spyre Therapeutics logo with Medical background

ADAR1 Capital Management LLC Increases Stock Position in Spyre Therapeutics, Inc. $SYRE

MarketBeat
NASDAQ:SYRE
Read ADAR1 Capital Management LLC Increases Stock Position in Spyre Therapeutics, Inc. $SYRE
Rhythm Pharmaceuticals logo with Medical background

Rhythm Pharmaceuticals, Inc. $RYTM Position Raised by ADAR1 Capital Management LLC

MarketBeat
NASDAQ:RYTM
Read Rhythm Pharmaceuticals, Inc. $RYTM Position Raised by ADAR1 Capital Management LLC
Scholar Rock logo with Medical background

ADAR1 Capital Management LLC Grows Stake in Scholar Rock Holding Corporation $SRRK

MarketBeat
NASDAQ:SRRK
Read ADAR1 Capital Management LLC Grows Stake in Scholar Rock Holding Corporation $SRRK
Inspire Medical Systems logo with Medical background

ADAR1 Capital Management LLC Purchases 390,197 Shares of Inspire Medical Systems, Inc. $INSP

MarketBeat
NYSE:INSP
Read ADAR1 Capital Management LLC Purchases 390,197 Shares of Inspire Medical Systems, Inc. $INSP
Anteris Technologies Global logo with Medical background

ADAR1 Capital Management LLC Raises Stake in Anteris Technologies Global Corp. $AVR

MarketBeat
NASDAQ:AVR
Read ADAR1 Capital Management LLC Raises Stake in Anteris Technologies Global Corp. $AVR
DBV Technologies logo with Medical background

ADAR1 Capital Management LLC Acquires New Shares in DBV Technologies S.A. $DBVT

MarketBeat
NASDAQ:DBVT
Read ADAR1 Capital Management LLC Acquires New Shares in DBV Technologies S.A. $DBVT
Beam Therapeutics logo with Medical background

ADAR1 Capital Management LLC Buys Shares of 1,446,375 Beam Therapeutics Inc. $BEAM

MarketBeat
NASDAQ:BEAM
Read ADAR1 Capital Management LLC Buys Shares of 1,446,375 Beam Therapeutics Inc. $BEAM
Crinetics Pharmaceuticals logo with Medical background

Crinetics Pharmaceuticals, Inc. $CRNX is ADAR1 Capital Management LLC's 8th Largest Position

MarketBeat
NASDAQ:CRNX
Read Crinetics Pharmaceuticals, Inc. $CRNX is ADAR1 Capital Management LLC's 8th Largest Position

Featured Articles and Offers

RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
tc pixel
The end may be near for these iconic stocks
The end may be near for these iconic stocks
From Chaikin Analytics (Ad)
AMD’s AI Bubble Could Burst Into Explosive Upside
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
By Jeffrey Neal Johnson | July 22, 2026
Boxabl Disrupts Housing With A Tiny Float IPO
Boxabl Disrupts Housing With A Tiny Float IPO
By Jeffrey Neal Johnson | July 22, 2026
tc pixel
What's the Best Way to Lower RMD Taxes?
What's the Best Way to Lower RMD Taxes?
From SmartAsset (Ad)
Broadcom May Be the Biggest Winner From Alphabet's Earnings
Broadcom May Be the Biggest Winner From Alphabet's Earnings
By Leo Miller | July 26, 2026
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
By Thomas Hughes | July 27, 2026

Alert Categories

All Alerts
Page 1 of 617